Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Levy

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
Shock (Augusta, Ga.)|November 15, 2016
High Versus Low Blood-Pressure Target in Experimental Ischemic Prolonged Cardiac Arrest Treated with Extra Corporeal Life SupportCaroline Fritz, Antoine Kimmoun, Fabrice Vanhuyse, et al.
Critical Care Medicine|February 28, 2025
Dexmedetomidine to Reduce Vasopressor Resistance in Refractory Septic Shock: α2 Agonist Dexmedetomidine for REfractory Septic Shock (ADRESS): A Double-Blind Randomized Controlled Pilot TrialAuguste Dargent, Abderrahmane Bourredjem, Marine Jacquier, et al.
Shock (Augusta, Ga.)|February 6, 2016
Beneficial Effects of Norepinephrine Alone on Cardiovascular Function and Tissue Oxygenation in a Pig Model of Cardiogenic ShockAlexandra Beurton, Nicolas Ducrocq, Thomas Auchet, et al.
Critical Care Medicine|December 11, 2012
Methylene blue and epinephrine: a synergetic association for anaphylactic shock treatmentFeng Zheng, Grégoire Barthel, Olivier Collange, et al.
Resuscitation|May 18, 2024
Hypothermia in patients with cardiac arrest prior to ECMO-VA: Insight from the HYPO-ECMO trialBruno Levy, Nicolas Girerd, Kevin Duarte, et al.
Critical Care (London, England)|March 27, 2025
Association between mean hemodynamic variables during the first 24 h and outcomes in cardiogenic shock: identification of clinically relevant thresholdsBruno Levy, Anais Curtiaud, Kevin Duarte, et al.
Critical Care (London, England)|August 1, 2025
Targeting high circulating dipeptidyl peptidase 3 in circulatory failureAdrien Picod, Feriel Azibani, Veli-Pekka Harjola, et al.
Annals of Intensive Care|June 21, 2023
Prognostic value of respiratory compliance course on mortality in COVID-19 patients with vv-ECMOSimon Valentin, Mathieu Amalric, Guillaume Granier, et al.
Archives of Cardiovascular Diseases|September 18, 2025
Clinical impact of congestion in patients admitted for cardiogenic shockMiloud Cherbi, François Roubille, Eric Bonnefoy, et al.
European Journal of Heart Failure|September 1, 2019
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trialKoji Takagi, Alice Blet, Bruno Levy, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
Shock (Augusta, Ga.)|November 15, 2016
High Versus Low Blood-Pressure Target in Experimental Ischemic Prolonged Cardiac Arrest Treated with Extra Corporeal Life SupportCaroline Fritz, Antoine Kimmoun, Fabrice Vanhuyse, et al.
Critical Care Medicine|February 28, 2025
Dexmedetomidine to Reduce Vasopressor Resistance in Refractory Septic Shock: α2 Agonist Dexmedetomidine for REfractory Septic Shock (ADRESS): A Double-Blind Randomized Controlled Pilot TrialAuguste Dargent, Abderrahmane Bourredjem, Marine Jacquier, et al.
Shock (Augusta, Ga.)|February 6, 2016
Beneficial Effects of Norepinephrine Alone on Cardiovascular Function and Tissue Oxygenation in a Pig Model of Cardiogenic ShockAlexandra Beurton, Nicolas Ducrocq, Thomas Auchet, et al.
Critical Care Medicine|December 11, 2012
Methylene blue and epinephrine: a synergetic association for anaphylactic shock treatmentFeng Zheng, Grégoire Barthel, Olivier Collange, et al.
Resuscitation|May 18, 2024
Hypothermia in patients with cardiac arrest prior to ECMO-VA: Insight from the HYPO-ECMO trialBruno Levy, Nicolas Girerd, Kevin Duarte, et al.
Critical Care (London, England)|March 27, 2025
Association between mean hemodynamic variables during the first 24 h and outcomes in cardiogenic shock: identification of clinically relevant thresholdsBruno Levy, Anais Curtiaud, Kevin Duarte, et al.
Critical Care (London, England)|August 1, 2025
Targeting high circulating dipeptidyl peptidase 3 in circulatory failureAdrien Picod, Feriel Azibani, Veli-Pekka Harjola, et al.
Annals of Intensive Care|June 21, 2023
Prognostic value of respiratory compliance course on mortality in COVID-19 patients with vv-ECMOSimon Valentin, Mathieu Amalric, Guillaume Granier, et al.
Archives of Cardiovascular Diseases|September 18, 2025
Clinical impact of congestion in patients admitted for cardiogenic shockMiloud Cherbi, François Roubille, Eric Bonnefoy, et al.
European Journal of Heart Failure|September 1, 2019
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trialKoji Takagi, Alice Blet, Bruno Levy, et al.
Pageof 23